Wall Street analysts expect Imperva Inc (NYSE:IMPV) to post $82.29 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Imperva’s earnings. The highest sales estimate is $82.98 million and the lowest is $82.01 million. Imperva reported sales of $68.41 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 20.3%. The company is expected to issue its next quarterly earnings results on Thursday, November 2nd.

According to Zacks, analysts expect that Imperva will report full year sales of $82.29 million for the current financial year, with estimates ranging from $320.90 million to $322.76 million. For the next financial year, analysts anticipate that the firm will post sales of $379.23 million per share, with estimates ranging from $369.00 million to $386.30 million. Zacks’ sales averages are a mean average based on a survey of research analysts that cover Imperva.

Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.15). The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm’s quarterly revenue was up 28.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.23) EPS.

Several research firms have recently weighed in on IMPV. Evercore ISI set a $56.00 price objective on Imperva and gave the company a “buy” rating in a research report on Thursday, August 10th. BidaskClub cut Imperva from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 5th. Monness Crespi & Hardt increased their price objective on Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price objective on Imperva and gave the company a “buy” rating in a research report on Monday, August 28th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $47.00 price objective on shares of Imperva in a research report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Imperva has an average rating of “Buy” and an average price target of $52.97.

COPYRIGHT VIOLATION WARNING: This story was first posted by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/09/16/imperva-inc-impv-expected-to-announce-quarterly-sales-of-82-29-million.html.

Shares of Imperva (NYSE:IMPV) opened at 44.10 on Friday. The company’s market cap is $1.49 billion. Imperva has a 52 week low of $34.40 and a 52 week high of $57.24. The company has a 50 day moving average of $44.19 and a 200-day moving average of $45.49.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.20% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of IMPV. Teachers Advisors LLC lifted its position in Imperva by 4.4% in the fourth quarter. Teachers Advisors LLC now owns 47,262 shares of the software maker’s stock worth $1,815,000 after purchasing an additional 1,972 shares during the period. Wells Fargo & Company MN lifted its position in Imperva by 33.2% in the first quarter. Wells Fargo & Company MN now owns 102,511 shares of the software maker’s stock worth $4,208,000 after purchasing an additional 25,530 shares during the period. Chicago Equity Partners LLC bought a new position in Imperva in the first quarter worth $444,000. First Trust Advisors LP lifted its position in Imperva by 35.2% in the first quarter. First Trust Advisors LP now owns 154,591 shares of the software maker’s stock worth $6,346,000 after purchasing an additional 40,263 shares during the period. Finally, US Bancorp DE lifted its position in Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after purchasing an additional 3,163 shares during the period. 92.72% of the stock is owned by hedge funds and other institutional investors.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.